DOSE-RESPONSE MODELING OF RECOMBINANT HUMAN ERYTHROPOIETIN (rhEPO) IN CHROMIC RENAL FAILURE (CRF) PATIENTS

Bae K.S. (Dept. of Pharmacol, and Clin. Pharmacol. Unit, College of Med. and SNU Hosp.) ;
Yu K.S. (Dept. of Pharmacol, and Clin. Pharmacol. Unit, College of Med. and SNU Hosp.) ;
Jang I.J. (Dept. of Pharmacol, and Clin. Pharmacol. Unit, College of Med. and SNU Hosp.) ;
Shin S.G. (Dept. of Pharmacol, and Clin. Pharmacol. Unit, College of Med. and SNU Hosp.) ;
Park C.W. (Dept. of Pharmacol, and Clin. Pharmacol. Unit, College of Med. and SNU Hosp.) ;
Lim C.S. (Dept. of Internal Med., SNU College of Med. and SNU Hosp.) ;
Park J.S. (Dept. of Pharmacol. and Clin. Pharmacol. Unit, Univ. of Ulsan. College of Med.) ;
Oh H.Y. (Dept. of Pharmacol. and Clin. Pharmacol. Unit, Sungkyunkwan Univ. College of Med.) ;
Ahn C. (Dept. of Internal Med. SNU College of Med. and SNU Hosp.)